rs36020

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_001172501.3(SLC6A2):c.645-5967C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.114 (AC=17,255) in the gnomAD database across 151,980 control chromosomes, including 1,082 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.159. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1082 hom., cov: 32)

Consequence

SLC6A2
NM_001172501.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.28

Publications

8 publications found
Variant links:
Genes affected
SLC6A2 (HGNC:11048): (solute carrier family 6 member 2) This gene encodes a member of the sodium:neurotransmitter symporter family. This member is a multi-pass membrane protein, which is responsible for reuptake of norepinephrine into presynaptic nerve terminals and is a regulator of norepinephrine homeostasis. Mutations in this gene cause orthostatic intolerance, a syndrome characterized by lightheadedness, fatigue, altered mentation and syncope. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
SLC6A2 Gene-Disease associations (from GenCC):
  • postural orthostatic tachycardia syndrome due to NET deficiency
    Inheritance: AD, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001172501.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.1586 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001172501.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC6A2
NM_001172501.3
MANE Select
c.645-5967C>T
intron
N/ANP_001165972.1P23975-1
SLC6A2
NM_001172504.1
c.645-5967C>T
intron
N/ANP_001165975.1P23975-2
SLC6A2
NM_001043.3
c.645-5967C>T
intron
N/ANP_001034.1P23975-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC6A2
ENST00000568943.6
TSL:1 MANE Select
c.645-5967C>T
intron
N/AENSP00000457473.1P23975-1
SLC6A2
ENST00000379906.6
TSL:1
c.645-5967C>T
intron
N/AENSP00000369237.2P23975-1
SLC6A2
ENST00000219833.13
TSL:5
c.645-5967C>T
intron
N/AENSP00000219833.8P23975-2

Frequencies

GnomAD3 genomes
AF:
0.114
AC:
17241
AN:
151886
Hom.:
1078
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0590
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.101
Gnomad ASJ
AF:
0.133
Gnomad EAS
AF:
0.168
Gnomad SAS
AF:
0.0788
Gnomad FIN
AF:
0.168
Gnomad MID
AF:
0.173
Gnomad NFE
AF:
0.139
Gnomad OTH
AF:
0.120
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.114
AC:
17255
AN:
151980
Hom.:
1082
Cov.:
32
AF XY:
0.114
AC XY:
8432
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.0589
AC:
2444
AN:
41464
American (AMR)
AF:
0.101
AC:
1544
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
462
AN:
3466
East Asian (EAS)
AF:
0.168
AC:
869
AN:
5178
South Asian (SAS)
AF:
0.0794
AC:
381
AN:
4800
European-Finnish (FIN)
AF:
0.168
AC:
1764
AN:
10512
Middle Eastern (MID)
AF:
0.193
AC:
56
AN:
290
European-Non Finnish (NFE)
AF:
0.139
AC:
9422
AN:
67994
Other (OTH)
AF:
0.124
AC:
261
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
790
1580
2370
3160
3950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.126
Hom.:
1871
Bravo
AF:
0.107
Asia WGS
AF:
0.130
AC:
452
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.162
AC:
19847
AN:
122456
Turkish Variome
AF:
0.106
AC:
164
AN:
1546
Hom.:
14
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.181
AC:
1622
AN:
8960
Hom.:
154
ABraOM SABE-WGS-1171
AF:
0.128
AC:
300
AN:
2342
Hom.:
18

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.075
DANN
Benign
0.21
PhyloP100
-3.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.